ProjectCIT003 – COT003-01 Phase III DBRMC Controlled study to evaluate efficacy an safety of intravenous L-citrulline…
Basic data
Acronym:
CIT003
Title:
COT003-01 Phase III DBRMC Controlled study to evaluate efficacy an safety of intravenous L-citrulline for the prevention of clinical sequelae of ALI inuced by CPB
Duration:
23/10/2017 to 31/12/2022
Abstract / short description:
CIT003-01
A Phase III Double blind randomized muli center Controlled study to evaluate efficacy an safety of intravenous L-citrulline for the prevention of clinical sequelae of ALI inuced by CPB undergoing surgery for congenital heart defects
A Phase III Double blind randomized muli center Controlled study to evaluate efficacy an safety of intravenous L-citrulline for the prevention of clinical sequelae of ALI inuced by CPB undergoing surgery for congenital heart defects
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen
University of Tübingen
Faculty of Medicine
University of Tübingen
University of Tübingen
Faculty of Medicine
University of Tübingen
University of Tübingen
Faculty of Medicine
University of Tübingen
University of Tübingen
Faculty of Medicine
University of Tübingen
University of Tübingen
Kling, Steffen
Faculty of Medicine
University of Tübingen
University of Tübingen
Faculty of Medicine
University of Tübingen
University of Tübingen
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
Paediatrics Department II and Polyclinic
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Baltimore, Maryland, United States